HMGB1 and cancer: Specifically, it has been demonstrated that HMGB1 release from dying cancer cells enhances antigen processing and presentation on dendritic cells (DCs) through the TLR4-MyD88 axis, a process that occurs during chemotherapy or radiotherapy [119,120].